2026-526096-31-00RecruitingPhase 1
A Randomized Study in Healthy Participants to Identify the Optimal Subcutaneous Injection Strategy for COR-1167
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
- Corteria Pharmaceuticals
- Enrollment
- 20
- Locations
- 2
Study Overview
Brief Summary
No summary available.
Eligibility Criteria
- Ages
- 18 years to 65+ years (18-64 Years, 65+ Years)
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Investigators
Chief Medical Officer - Francesca Lawson
Scientific
Corteria Pharmaceuticals
Study Sites (2)
Loading locations...
Similar Trials
Not yet recruiting
Phase 1
A study in healthy people or otherwise healthy with overweight or obesity to compare 2 formulations of survodutide given in different ways, either as a pre-filled syringe or a pen-like injectorHealthy volunteer trial2024-519614-30-00Boehringer Ingelheim International GmbH56
Recruiting
Phase 1
A study in healthy people or otherwise healthy but overweight or obese to compare 2 formulations of survodutide given in different ways, either as a pre-filled syringe or a pen-like injectorHealthy volunteer trial2025-524135-39-00Boehringer Ingelheim International GmbH56
Recruiting
Phase 1
Study in healthy male participants to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as multiple intravenous injections as well as safety, tolerability and the effects on certain blood values.Treatment of symptomatic anemia associated with chronic renal failure:2025-522246-43-00Blau Farmaceutica S.A.124
Completed
Phase 1
A two-part trial in healthy volunteers to find out how long JNJ-77242113 stays in and acts on the body when administered as different tablet formulations and under different food and water conditions, and to assess the acceptability profile (taste, palatability, and smell) of JNJ-77242113 formulations.Inflammatory Conditions2024-512220-11-00Janssen Cilag International76
Recruiting
Phase 1
A study in healthy people to test how 3 different formulations of BI 764198 are taken up in the body and how this is influenced by foodhealthy volunteer trial2024-519615-34-00Boehringer Ingelheim International GmbH17